Abionyx Pharma: Pioneering New Therapies for Kidney, Eye, and Metabolic Disorders
Abionyx Pharma SA is pioneering novel therapies for renal and eye diseases, with flagship candidates CER‑001, CER‑002, and CER‑209 targeting heart, metabolic, and liver disorders.
2 minutes to read